What pharmas and distributors are saying about market shortages in medicines

The problem of the lack of medicines in the Greek market has reached explosive proportions, resulting in an acute social problem and insecurity prevailing among thousands of patients.

The Panhellenic Union of the Pharmaceutical Industry (PEF) intervened on the issue, stressing that "at this time, 42 Greek drug producing factories are operating day and night at full capacity, to meet the needs of Greek patients".

As PEF points out, "Greek production continues unabated, despite the adverse environment made up by the continuous price reductions in old drugs, the huge clawback and overtaxation that reaches 70%, the increase in production costs and high inflation".

What the PM's first meetings of 2023 augur Charge absorption

According to PEF, these charges are absorbed entirely by the pharmaceutical companies and are not passed on to consumers. Especially in the last year, there have been huge problems in the global supply chain of medicines and raw materials, resulting in long delays and shortages in the supply of the market. Unfortunately, the phenomenon became more intense due to the seasonal upsurge of infections after two years of significant recession, emphasizes the PEF.

In her announcement, she notes that in Greece we are in a much better position than other European countries due to the existence of domestic production and adds that from September this year until November, the Greek pharmaceutical industries produced more than 25 million packages of medicines every month . If this had not been done, today we would be facing huge shortages even of drugs for chronic conditions such as anti-lipid, anti-hypertensive and heart failure drugs. At the same time, the Greek pharmaceutical industry continues to continuously supply the...

Continue reading on: